NURO – $3,800 Short Sale

Short selling NURO Stock on Collaboration PR.

NURO (NeuroMetrix) jumped 94% today on news of a drug collaboration. This PR release shows promise for their leading drug making it to market, however, they only retained rights for the US. The fact that they had to give up their international rights is worrying, and when combined with their weak balance sheet, an unjustified overextension was created.